LoginRegister
    AstraZeneca joins hands with NASSCOM to address burden of NCDs in IndiaAstraZeneca joins hands with NASSCOM to address burden of NCDs in India
    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: ReportNPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report
    Dr Reddys re-launches Buprenorphine, Naloxone Sublingual Film in US marketDr Reddy's re-launches Buprenorphine, Naloxone Sublingual Film in US market
    Alembic Pharma gets USFDA nod for Acetazolamide extended release capsulesAlembic Pharma gets USFDA nod for Acetazolamide extended release capsules
    Abbott, Novo Nordisk enters partnership to provide digital solution for diabetes managementAbbott, Novo Nordisk enters partnership to provide digital solution for diabetes management
    Canada to unveil budget, outline better drug coverageCanada to unveil budget, outline better drug coverage
    U.S. health spending to hit $6 trillion by 2027- CMSU.S. health spending to hit $6 trillion by 2027- CMS
    Cipla to acquire 11.71 percent stake in Wellthy TherapeuticsCipla to acquire 11.71 percent stake in Wellthy Therapeutics
    Srinagar: Doctors to boycott Zydus, Macleods, Intas, Sun pharma for suspending Kashmiri employeesSrinagar: Doctors to boycott Zydus, Macleods, Intas, Sun pharma for suspending Kashmiri employees
    Income Tax Department raids Divis Lab head office, manufacturing sitesIncome Tax Department raids Divis Lab head office, manufacturing sites
    Nestle India to launch nearly three dozen products in 2019, eyes higher exportsNestle India to launch nearly three dozen products in 2019, eyes higher exports
    US doctors overprescribed restricted drug fentanyl to patientsUS doctors overprescribed restricted drug fentanyl to patients
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X